SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-190461
Filing Date
2014-05-09
Accepted
2014-05-08 18:55:57
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d690364d10q.htm 10-Q 489739
2 EX-10.1 d690364dex101.htm EX-10.1 66541
3 EX-31.1 d690364dex311.htm EX-31.1 7160
4 EX-32.1 d690364dex321.htm EX-32.1 4286
  Complete submission text file 0001193125-14-190461.txt   3674642

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rgls-20140331.xml EX-101.INS 450775
6 XBRL TAXONOMY EXTENSION SCHEMA rgls-20140331.xsd EX-101.SCH 34704
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgls-20140331_cal.xml EX-101.CAL 43848
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgls-20140331_def.xml EX-101.DEF 215317
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgls-20140331_lab.xml EX-101.LAB 303896
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgls-20140331_pre.xml EX-101.PRE 249133
Mailing Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35670 | Film No.: 14826588
SIC: 2834 Pharmaceutical Preparations